New PPP to develop pediatric formulation to treat schistosomiasis
The objective of the partnership is to develop a formulation of praziquantel more suited to young children. Merck Serono, the biopharmaceutical division of Merck, global drug development and
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.